18-Aug-2026 16:11:38

SHILPA MEDICARE LIMITED : RECALLS 27,923 VIALS OF CHEMOTHERAPY DRUG IN US

• Voluntary recall initiated on July 29, 2026, at the retail/hospital level for Pemetrexed Injection 100 mg/10 mL and 500 mg/50 mL (Pemetri RTU™). • Recall covers 04 batches (02 of each strength) due to atypical discoloration described as green to dark green. • The recall has been classified by the US FDA as a Class II (hospital level) recall. • No adverse event has been reported to the company; recall confined to affected batches and does not affect other products. • Company does not foresee any material impact on financial position, operations, or other affairs. Impact: Neutral (Product recall due to discoloration, classified as Class II by US FDA)

Shilpa Medicare Limited

← Back to feed